Medication

Ended Awarded

Contract number
36C26118F1732
Awardee
Awarding agency
Obligated
$89,094

Award facts

Contract value 100% obligated
$89,094.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Cambridge, MA 02142, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Genzyme Corporation, doing business as Sanofi Genzyme, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $89,094.00 order is for the delivery of various specialty pharmaceutical products, including Eliglustat (Cerdelga), Lemtrada, and Caprelsa (vandetanib), to support treatment programs for veterans. Genzyme Corporation serves as the prime contractor, with no set-aside designation applied. The order has an ultimate completion date of September 30, 2018. Genzyme Corporation holds two major federal contract IDVs for pharmaceuticals, including the $659 million Pharmaceuticals and Drugs FSS-61-IB contract and a $4 million single-award Blanket Purchase Agreement (BPA) from the VA National Acquisition Center specifically for Lemtrada and Cerdelga, which provide federal healthcare agencies efficient access to its pharmaceutical product portfolio.

Quick answers

Who was awarded contract 36C26118F1732?

36C26118F1732 was awarded to Genzyme Corporation by Veterans Integrated Service Network 21 (Veterans Health Administration) on May 15, 2018.

How much is contract 36C26118F1732 worth?

The government has obligated $89,094 on 36C26118F1732.

Is contract 36C26118F1732 an order under another contract?

Yes. 36C26118F1732 is a delivery order under V797P2086D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26118F1732 competed?

The extent of competition for 36C26118F1732 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award